Antibody-Drug Conjugates (ADCs): current and future biopharmaceuticals.

J Hematol Oncol · 2025 · PMC12044742 · PMID 40307936

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a positive trendno p-value reported

These results indicate that SAR408701 did not meet its primary objective of independent review committee-assessed PFS but showed a positive trend on the OS at this interim analysis.

also in 11,005 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.